Literature DB >> 7476084

In vivo proton MR spectroscopy of human gliomas: definition of metabolic coordinates for multi-dimensional classification.

G Hagberg1, A P Burlina, I Mader, W Roser, E W Radue, J Seelig.   

Abstract

Several multi-dimensional statistical evaluation methods were applied to single-voxel proton MR spectra of glial brain tumors and of healthy volunteers. Metabolic coordinates with histological relevance for future diagnosis were found by which spectra from controls, low-grade tumors, and high-grade tumors were completely separated. Significant differences between low-grade and high-grade glioma patients and controls were found for several metabolic ratios by variance analysis. Cluster analysis both with and without principal component analysis was applied. The outcome of these two approaches depended mainly on the lipid-to-creatine ratio. Two other approaches, discriminant factor analysis and the orthonormal discriminant vector method were then used to find discriminatory metabolic coordinates. It turned out that a linear combination of all evaluable metabolic ratios made it possible to separate the three groups completely. On the basis of these results, a classification method that uses the entire proton MRS spectrum is proposed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7476084     DOI: 10.1002/mrm.1910340216

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  8 in total

1.  Molecular classification of brain tumor biopsies using solid-state magic angle spinning proton magnetic resonance spectroscopy and robust classifiers.

Authors:  Ovidiu C Andronesi; Konstantinos D Blekas; Dionyssios Mintzopoulos; Loukas Astrakas; Peter M Black; A Aria Tzika
Journal:  Int J Oncol       Date:  2008-11       Impact factor: 5.650

Review 2.  MR spectroscopy: a powerful tool for investigating brain function and neurological diseases.

Authors:  A P Burlina; T Aureli; F Bracco; F Conti; L Battistin
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

3.  Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas.

Authors:  H Shimizu; T Kumabe; R Shirane; T Yoshimoto
Journal:  AJNR Am J Neuroradiol       Date:  2000-04       Impact factor: 3.825

4.  Assignment of glial brain tumors in humans by in vivo 1H-magnetic resonance spectroscopy and multidimensional metabolic classification.

Authors:  W Roser; G Hagberg; I Mader; S Dellas; J Seelig; E W Radue; W Steinbrich
Journal:  MAGMA       Date:  1997-09       Impact factor: 2.310

5.  Arterial spin-labeling and MR spectroscopy in the differentiation of gliomas.

Authors:  S Chawla; S Wang; R L Wolf; J H Woo; J Wang; D M O'Rourke; K D Judy; M S Grady; E R Melhem; H Poptani
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-24       Impact factor: 3.825

6.  Preoperative proton-MR spectroscopy of gliomas--correlation with quantitative nuclear morphology in surgical specimen.

Authors:  Reinhold Nafe; Sebastian Herminghaus; Peter Raab; Sabine Wagner; Ulrich Pilatus; Berthold Schneider; Wolfgang Schlote; Friedhelm Zanella; Heinrich Lanfermann
Journal:  J Neurooncol       Date:  2003-07       Impact factor: 4.130

7.  The integrative metabolomic-transcriptomic landscape of glioblastome multiforme.

Authors:  Dieter Henrik Heiland; Jakob Wörner; Jan Gerrit Haaker; Daniel Delev; Nils Pompe; Bianca Mercas; Pamela Franco; Annette Gäbelein; Sabrina Heynckes; Dietmar Pfeifer; Stefan Weber; Irina Mader; Oliver Schnell
Journal:  Oncotarget       Date:  2017-07-25

8.  SPectroscOpic prediction of bRain Tumours (SPORT): study protocol of a prospective imaging trial.

Authors:  Pamela Franco; Urs Würtemberger; Karam Dacca; Irene Hübschle; Jürgen Beck; Oliver Schnell; Irina Mader; Harald Binder; Horst Urbach; Dieter Henrik Heiland
Journal:  BMC Med Imaging       Date:  2020-11-23       Impact factor: 1.930

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.